Therefore, it was also confirmed that anti-IL-6 receptor monoclonal antibodies can ameliorate the inflammation in burn mice in addition to anti-IL-6 monoclonal antibodies (Pallua et al., 2003) As the studies of IL-6 signal transduction pathways continue, IL-6 had emerged as a potential target for treatment of sepsis. This evidence concerns the gene IL6 and Sepsis.